Pitavastatin Tablets in 1 mg, 2 mg, and 4 mg strengths
Maple Grove, MN – November 6, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Pitavastatin Tablets in 1 mg, 2 mg, and ... Read More
Recognized by NCPA for Exemplary Leadership and Commitment to Independent Pharmacy
NCPA’s 2023 Willard B. Simmons Independent Pharmacist of the Year Award Presentation. Left to Right: NCPA President Hugh Chancy, RPh; Theresa Tolle, BSPharm, FAPhA (winner); ... Read More
Maple Grove, MN – August 21, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of Mesalamine Extended-Release Capsules, USP 375 mg. The mesalamine capsule market had U.S. sales of approximately $105 million ... Read More
Maple Grove, MN – August 15, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of Famotidine for Oral Suspension, USP. The Famotidine Oral Suspension market had U.S. sales of approximately $73 million ... Read More
Offers a Fully Substitutable Generic Alternative with Physician, Patient, and Caregiver Support
Maple Grove, MN – August 1, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of VIGADRONE® (vigabatrin) Tablets, USP 500 ... Read More
Isotretinoin Capsules, USP in 10 mg, 20 mg, 30 mg, and 40 mg strengths.Upsher-Smith Laboratories, LLC
Maple Grove, MN – July 24, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of Isotretinoin Capsules, ... Read More
Maple Grove, MN – June 26, 2023 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has entered into a definitive agreement under which New Jersey-based Tonix Pharmaceuticals Holding Corp. (Tonix Pharmaceuticals) and its wholly ... Read More
